Recent Headlines/Sample Articles	Date
Amgen Data on T-Vec to Be Published This Week	05/13/2013
Specialty Pharmaceutical Revenue Growth Driven by Niche Demand	05/06/2013
Biotech Company Owns Clinical Trial Property Held by CRO	04/29/2013
Avanir May Gain Second Regulatory Backing for Nuedexta	04/22/2013
Diabetes Market Growing in China	04/15/2013
Litigation Restricts Cash-Poor on U.S. Biosimilar Path	03/25/2013
Additional Data May Clarify Boston’s Watchman Mixed Results, Chances for Approval	03/18/2013
Biogen’s Recombinant Factors for Hemophilia May Provide Breakthrough for Patients	03/11/2013

Insight.
Delivered.

Newsletters For Professionals,
From Professionals.

Who's it for?

The financial community interested in healthcare sector investments

• >>Industry Consultants
• >>Pharma, Biotech and Device Executives

In every issue:

• Analysis from Bloomberg Industries, BGOV, BLAW and BNA
• Key Catalyst: Detailed look at upcoming events affecting the sector
• Patent Watch: Most recent lawsuits filed as tracked by BLAW
• Latest FDA and EMEA regulatory activity impacting pharmaceutical and medical device development
• Compounds and devices in development and milestone announcements
• M&A, partnership, and collaboration opportunities, and technology transfer deals